Tom Harwood has written a rather good Substack post about the new weight loss drug semaglutide (brand name: Wegovy). Although I am not as convinced as some people that this is a panacea for obesity, it has been interesting to witness the dismay from moralists who are worried that this will 'let junk food companies off the hook'.
One forecaster from The Swift Centre explains that, on a back of a napkin calculation, the 20% fattest brits taking up semaglutide could save the UK economy billions. “the cost would be over £9bn a year just to treat 20% of the population. The NHS says obesity costs the organization £6.1bn a year, but £27bn to wider society. Political silliness about paying a single or small number of drug companies such a large amount of money might also cause hesitancy.” That seems like a decent investment to make.
The hilarious thing about all of this is that despite the government now seeing itself taking on a feng shui interior decoration role when it comes to supermarkets - this grand plan doesn’t appear to be working. Retailers are reporting confectionery sales rising, not falling.
Spar retailer Julian Taylor-Green, who owns a 2,500 sq ft store in Stafford, said confectionery sales had gone up by 11.5% in the past year, while crisps and snacks rose 14.1%.
“While inflation will play a part in this, I feel this has happened because we’ve now moved HFSS products that were by the tills and on promotional bays all into one place on the confectionery aisle, which has made that shopping experience easier for the customer to access these products,” he said.
If it has, can we please stop listening to ignorant 'public health' academics who do not understand the market they are trying to regulate?
No comments:
Post a Comment
Comments are only moderated after 14 days.